Culture medium capable of amplifying number of endothelial progenitor cells
A technology of endothelial progenitor cells and culture medium, which is applied in the field of culture medium for expanding the number of endothelial progenitor cells, which can solve the problems of impaired function and low number of endothelial progenitor cells, reduce pollution, facilitate separation, and have good safety Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0014] Example one:
[0015] In this example, using EGM-2 as the basic medium, 10% fetal bovine serum, 5g / L soybean phytohydrolyzed protein, 10μg / L VEGF, 2μg / L bFGF, 20μg / L epidermal growth factor , 50μM vitamin C, 1μM AR-A014418.
[0016] This embodiment reduces the amount of fetal bovine serum used in conventional culture media, and uses soybean plant hydrolyzed protein, which has a lower cost than conventional culture media, and solves the problem of premature cell death and morphological unsaturation caused by reducing the use of fetal bovine serum. The problem of using AR-A014418 to amplify the number of endothelial progenitor cells.
Example Embodiment
[0017] Embodiment two:
[0018] In this example, under the condition of using EGM-2 as the basal medium, 10% fetal bovine serum was used, and then 10g / L of soybean plant hydrolyzed protein, 50μg / L of VEGF, 10μg / L of bFGF, 100μg were added to the medium / L epidermal growth factor, 200μM vitamin C, 5μM AR-A014418.
[0019] This embodiment reduces the amount of fetal bovine serum used in conventional culture media, and uses soybean plant hydrolyzed protein, which has a lower cost than conventional culture media, and solves the problem of premature cell death and morphological unsaturation caused by reducing the use of fetal bovine serum. The problem of using AR-A014418 to amplify the number of endothelial progenitor cells.
Example Embodiment
[0020] Embodiment three:
[0021] In this example, under the condition of using EGM-2 as the basal medium, 10% fetal bovine serum was used, and 7g / L soybean phytohydrolyzed protein, 30μg / L VEGF, 7μg / L bFGF, 70μg were added to the medium. / L epidermal growth factor, 100μM vitamin C, 3μM AR-A014418.
[0022] This embodiment reduces the amount of fetal bovine serum used in conventional culture media, and uses soybean plant hydrolyzed protein, which has a lower cost than conventional culture media, and solves the problem of premature cell death and morphological unsaturation caused by reducing the use of fetal bovine serum. The problem of using AR-A014418 to amplify the number of endothelial progenitor cells.
[0023] The low-serum culture medium developed by the present invention is similar in shape to conventionally cultured 20% fetal bovine serum, reduces pollution, facilitates the separation of downstream products of cells, and has good safety; compared with commercial culture mediu...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap